학술논문

Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 9 May 2023, 7(9):1858-1870)
Subject
Language
English
ISSN
24739537
24739529